Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
8,316 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01871363 | Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer | unknown | Phase 2 | 35 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT01218243 | An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia | completed | Phase 2 | 100 | Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER | 1 |
| May 27, 2013 |
| clinicaltrials |
| NCT01463501 | Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer | unknown | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT00077857 | A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 470 | Hoffmann-La RocheINDUSTRY | 9 | May 10, 2013 | clinicaltrials |
| NCT01850147 | Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT01798251 | XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach | unknown | Phase 2 | 40 | Harbin Medical UniversityOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | unknown | Phase 1 / Phase 2 | 40 | Fudan UniversityOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT01839539 | Study of DC-CIK to Treat Colorectal Cancer | unknown | Phase 2 | 60 | Guangxi Medical UniversityOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT01368419 | Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients | unknown | Phase 2 | 40 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01410370 | Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases | unknown | Phase 2 | 80 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01838538 | Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy | unknown | Phase 2 | 54 | Chinese PLA General HospitalOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01836991 | D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer | unknown | Phase 2 | 200 | Zhejiang Cancer HospitalOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT01836120 | A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer | unknown | Phase 2 | 100 | Hebei Tumor HospitalOTHER | 1 | Apr 19, 2013 | clinicaltrials |
| NCT01832948 | Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | Zhejiang Cancer HospitalOTHER | 1 | Apr 16, 2013 | clinicaltrials |
| NCT01821482 | A Study of DC-CIK to Treat Hepatocellular Carcinoma | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01821495 | Study of DC-CIK to Treat NPC | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01503502 | A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | unknown | Phase 2 | 150 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01826396 | Standard and High Dose Irinotecan Based on UGT1A1 Genotype for First-line Treatment of Locally Advanced Colon Cancer | unknown | Phase 2 | 100 | Colorectal Cancer Institute of the Heilongjiang Academy of Medical SciencesOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT01806272 | Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis | unknown | Phase 2 | 160 | Wei LUOOTHER | 1 | Mar 29, 2013 | clinicaltrials |
| NCT01394575 | Whole Breast Irradiation With Intensity Modulated Radiotherapy and Simultaneously Integrated Boost for Early Stage Breast Cancer Patients(IMRT-SIB) | unknown | Phase 2 | 190 | Fudan UniversityOTHER | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00494091 | Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma | completed | Phase 2 | 82 | PfizerINDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT01492543 | Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer | unknown | Phase 2 | 30 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01492556 | Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer | unknown | Phase 2 | 100 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01811277 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma(BTC)and Pancreatic Cancer | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01812018 | Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma | unknown | Phase 2 | 30 | Peng YuanUNKNOWN | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01431053 | Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer | unknown | Phase 2 | 160 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT01689558 | Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer | unknown | Phase 2 / Phase 3 | 60 | Jin FengOTHER | 1 | Mar 12, 2013 | clinicaltrials |
| NCT01735747 | Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma | unknown | Phase 2 | 16 | Rongjie TaoOTHER | 1 | Mar 12, 2013 | clinicaltrials |
| NCT01809392 | Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome | unknown | Phase 2 / Phase 3 | 15 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Mar 12, 2013 | clinicaltrials |
| NCT01278602 | R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma | unknown | Phase 2 | 50 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01333605 | IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma | unknown | Phase 2 | 43 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01333696 | Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck | unknown | Phase 2 | 32 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01667289 | Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma | terminated | Phase 2 | 4 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01667302 | Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma | unknown | Phase 2 | 30 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01804127 | Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCL | unknown | Phase 2 | 196 | Fudan UniversityOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01739465 | Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma | unknown | Phase 2 / Phase 3 | 120 | Guangzhou Medical UniversityOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01796288 | The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment(ROLE) | unknown | Phase 2 | 200 | Wu Jieping Medical FoundationOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 2 | 247 | Eli Lilly and CompanyINDUSTRY | 7 | Feb 13, 2013 | clinicaltrials |
| NCT01623102 | Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer | unknown | Phase 2 | 40 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT01782508 | A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma | unknown | Phase 2 | 40 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT01763450 | Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer | unknown | Phase 2 | 100 | Liaoning Cancer Hospital & InstituteOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01731548 | A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 500 | Zhejiang Cancer HospitalOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01737216 | Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer | unknown | Phase 2 | 100 | Hebei Tumor HospitalOTHER | 1 | Dec 31, 2012 | clinicaltrials |
| NCT01756183 | Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer | unknown | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | Dec 25, 2012 | clinicaltrials |
| NCT01755923 | Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT01749072 | Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 120 | Peking Union Medical College HospitalOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT01747707 | Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT00891579 | Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations | completed | Phase 2 | 161 | Chinese Society of Lung CancerOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT01746277 | Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy | unknown | Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 10, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials